Amniotic membrane: New concepts for an old dressing

Wound Repair and Regeneration

Volumn 22, Issue 4, 2014, Pages 451-456

  Litwiniuk, Malgorzata ^a   Grzela, Tomasz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYALURONIC ACID;

AMNION; DONOR; HUMAN; PRIORITY JOURNAL; REVIEW; WOUND CARE; WOUND DRESSING; BIOLOGICAL DRESSING; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; EPITHELIUM CELL; HEALTH CARE FACILITY; PATHOLOGY; TREATMENT OUTCOME; TRENDS; WOUND HEALING; WOUNDS AND INJURIES;

AMNION; BIOLOGICAL DRESSINGS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPITHELIAL CELLS; HUMANS; TISSUE BANKS; TISSUE DONORS; TREATMENT OUTCOME; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84904627661     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12188     Document Type: Review

References (55)

1. Russo A, Bonci P, Bonci P,. The effects of different preservation processes on the total protein and growth factor content in a new biological product developed from human amniotic membrane. Cell Tissue Bank 2012; 13: 353-361.
2. Wolbank S, Hildner F, Redl H, van Griensven M, Gabriel C, Hennerbichler S,. Impact of human amniotic membrane preparation on release of angiogenic factors. J Tissue Eng Regen Med 2009; 3: 651-654.
3. Litwiniuk M, Bikowska B, Niderla-Bielińska J, Jõźwiak J, Kamiński A, Skopiński P, et al. High molecular weight hyaluronan and stroma-embedded factors of radiation-sterilized amniotic membrane stimulate proliferation of HaCaT cell line in vitro. Centr Eur J Immunol 2011; 36: 205-211.
4. Tauzin H, Humbert P, Viennet C, Saas P, Muret P,. Human amniotic membrane in the management of chronic venous leg ulcers. Ann Dermatol Venereol 2011; 138: 572-579.
5. Tyszkiewicz JT, Uhrynowska-Tyszkiewicz IA, Kaminski A, Dziedzic-Goclawska A,. Amnion allografts prepared in the Central Tissue Bank in Warsaw. Ann Transplant 1999; 4: 85-90.
6. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, Ghanavi J, Seifalian AM,. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater 2008; 15: 88-99. (Pubitemid 351955733)
7. Riau A, Beuerman RW, Lim LS, Mehta J,. Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials 2010; 31: 216-225.
8. Fatima A, Sangwan VS, Iftekhar G, Reddy P, Matalia H, Balasubramanian D, et al. Technique of cultivating limbal derived corneal epithelium on human amniotic membrane for clinical transplantation. J Postgrad Med 2006; 52: 257-261. (Pubitemid 44862763)
9. Yang L, Shirakata Y, Shudou M, Dai X, Tokumaru S, Hirakawa S, et al. New skin-equivalent model from de-epithelialized amnion membrane. Cell Tissue Res 2006; 326: 69-77. (Pubitemid 44162539)
10. Mligiliche N, Endo K, Okamoto K, Fujimoto E, Ide C,. Extracellular matrix of human amnion manufactured into tubes as conduits for peripheral nerve regeneration. J Biomed Mater Res 2002; 63: 591-600.
11. Mohammad J, Shenaq J, Rabinovsky E, Shenaq S,. Modulation of peripheral nerve regeneration: a tissue-engineering approach. The role of amnion tube nerve conduit across a 1-centimeter nerve gap. Plast Reconstr Surg 2000; 105: 660-666. (Pubitemid 30111004)
12. Muralidharan S, Gu J, Laub GW, Cichon R, Daloisio C, McGrath LB,. A new biological membrane for pericardial closure. J Biomed Mater Res 1991; 25: 1201-1209. (Pubitemid 21712003)
13. Zmijewski M, Pietraszek A,. The application of deep-frozen and radiation-sterilized human amnion as a biological dressing to prevent prolonged air leakage in thoracic surgery. Ann Transplant 2005; 10: 17-20.
14. Meller D, Pauklin M, Thomasen H, Westekemper H, Steuhl KP,. Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int 2011; 108: 243-248.
15. Andonovska D, Dzokic G, Spasevska L, Trajkovska T, Popovska K, Todorov I, et al. The advantages of the application of amnion membrane in the treatment of burns. Prilozi 2008; 29: 183-198.
16. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M,. Growth factors and cytokines in wound healing. Wound Repair Regen 2008; 16: 585-601.
17. Cheung CY, Singh M, Ebaugh MJ, Brace RA,. Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 1995; 173: 753-759.
18. Horibe N, Okamoto T, Itakura A, Nakanishi T, Suzuki T, Kazeto S, et al. Levels of hepatocyte growth factor in maternal serum and amniotic fluid. Am J Obstet Gynecol 1995; 173: 937-942.
19. Rowe TF, King LA, MacDonald PC, Casey ML,. Tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 expression in human amnion mesenchymal and epithelial cells. Am J Obstet Gynecol 1997; 176: 915-921. (Pubitemid 27202956)
20. Hill DJ, Clemmons DR, Riley SC, Bassett N, Challis JR,. Immunohistochemical localization of insulin-like growth factors (IGFs) and IGF binding proteins -1, -2 and -3 in human placenta and fetal membranes. Placenta 1993; 14: 1-12. (Pubitemid 23082134)
21. Han VK, Bassett N, Walton J, Challis JR,. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 1996; 81: 2680-2693. (Pubitemid 26240297)
22. McKenna DS, Samuels P, Zimmerman PD, Kniss DA,. Interleukin-1 alpha, epidermal growth factor, and transforming growth factor-beta exhibit differential kinetics on endothelin-1 synthesis in amnion cells. J Soc Gynecol Investig 1998; 5: 25-30.
23. Hudson LG, McCawley LJ,. Contributions of the epidermal growth factor receptor to keratinocyte motility. Microsc Res Tech 1998; 43: 444-455. (Pubitemid 28565791)
24. Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ 3rd, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 1989; 321: 76-79. (Pubitemid 19170395)
25. Sogabe Y, Abe M, Yokoyama Y, Ishikawa O,. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen 2006; 14: 457-462. (Pubitemid 44266603)
26. Powers CJ, McLeskey SW, Wellstein A,. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000; 7: 165-197.
27. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F,. Sp1 is required for the early response of alpha2 (I) collagen to transforming growth factor-beta1. J Biol Chem 1997; 272: 19738-19745. (Pubitemid 27340064)
28. Ogawa K, Chen F, Kuang C, Chen Y,. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by a nuclear factor-κB site. Biochem J 2004; 381: 413-422. (Pubitemid 38969685)
29. Saito S, Trovato MJ, You R, Lal KB, Fasehun F, Padberg FT, et al. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg 2001; 34: 930-938. (Pubitemid 33661046)
30. Litwiniuk M, Bikowska B, Niderla-Bielińska J, Jõźwiak J, Kamiński A, Skopiński P, et al. Potential role of metalloproteinase inhibitors from radiation-sterilized amnion dressings in the healing of venous leg ulcers. Mol Med Rep 2012; 6: 723-728.
31. Skopiński P, Zdanowski R, Grzela T, Kamiński A, Lewicki S, Skopińska-Rõzewska E, et al. The influence of sterilized and non-sterilized amniotic dressings on the proliferation of endothelial cells in vitro. Centr Eur J Immunol 2012; 37: 114-118.
32. Noble PW,. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21: 25-29. (Pubitemid 34100819)
33. Jiang D, Liang J, Noble PW,. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007; 23: 435-461.
34. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11: 1173-1179. (Pubitemid 43093664)
35. Meinert M, Eriksen GV, Petersen AC, Helmig RB, Laurent C, Uldbjerg N, et al. Proteoglycans and hyaluronan in human fetal membranes. Am J Obstet Gynecol 2001; 184: 679-685. (Pubitemid 32234984)
36. Meinert M, Malmstro A, Tufvesson E, Westergren-Thorsson G, Petersen AC, Laurent C, et al. Labour induces increased concentrations of biglycan and hyaluronan in human fetal membranes. Placenta 2007; 28: 482-486. (Pubitemid 46593784)
37. McLaren J, Malak TM, Bell SC,. Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod 1999; 14: 237-241. (Pubitemid 29046345)
38. Lopez-Valladares MJ, Rodriguez-Ares MT, Tourin R, Gude F, Silva MT, Couceiro J,. Donor age and gestational age influence on growth factor levels in human amniotic membrane. Acta Ophthalmol 2010; 88: e211-216.
39. Gicquel JJ, Dua HS, Brodie A, Mohammed I, Suleman H, Lazutina E, et al. Epidermal growth factor variations in amniotic membrane used for ex vivo tissue constructs. Tissue Eng 2009; 15: 1919-1927.
40. Hopkinson A, McIntosh RS, Tighe PJ, James DK, Dua HS,. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci 2006; 47: 4316-4322. (Pubitemid 46579354)
41. Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ,. The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 2006; 27: 1037-1051. (Pubitemid 44400517)
42. Chen HC, Tan HY, Hsiao CH, Huang SC, Lin KK, Ma DH,. Amniotic membranȩ transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Cornea 2006; 25: 564-572. (Pubitemid 44620102)
43. Sangwan VS, Burman S, Tejwani S, Mahesh SP, Murthy R,. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol 2007; 55: 251-260.
44. Kaup M, Redbrake C, Plange N, Arend KO, Remky A,. Amniotic membrane transplantation in severe ocular surface disorders. Eur J Ophthalmol 2008; 18: 691-694.
45. Fernandes M, Sridhar MS, Sangwan VS, Rao GN,. Amniotic membrane transplantation for ocular surface reconstruction. Cornea 2005; 24: 643-653. (Pubitemid 41060923)
46. Letko E, Stechschulte SU, Kenyon KR, Sadeq N, Romero TR, Samson CM, et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001; 119: 655-663.
47. Fetterolf DE, Snyder RJ,. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds 2012; 24: 299-307.
48. Franz MG, Payne WG, Xing L, Naidu DK, Salas RE, Marshall VS, et al. The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wound models. Eplasty 2008; 11: e21.
49. Steed DL, Trumpower C, Duffy D, Smith CH, Marshall V, Rupp R, et al. Amnion-derived cellular cytokine solution. A physiological combination of cytokines for wound healing. Eplasty 2008; 7: e18.
50. Sangwan VS, Matalia HP, Vemuganti GK, Rao GN,. Amniotic membrane transplantation for reconstruction of corneal epithelial surface in cases of partial limbal stem cell deficiency. Indian J Ophthalmol 2004; 52: 281-285. (Pubitemid 40116025)
51. Bonci P, Bonci P, Lia A,. Suspension made with amniotic membrane: clinical trial. Eur J Ophthalmol 2005; 15: 441-445. (Pubitemid 41152962)
52. Liang L, Li W, Ling S, Sheha H, Qiu W, Li C, et al. Amniotic membrane extraction solution for ocular chemical burns. Clin Experiment Ophthalmol 2009; 37: 855-863.
53. Shahriari HA, Tokhmehchi F, Reza M, Hashemi NF,. Comparison of the effect of amniotic membrane suspension and autologous serum on alkaline corneal epithelial wound healing in the rabbit model. Cornea 2008; 27: 1148-1150.
54. Guo Q, Hao J, Yang Q, Guan L, Ouyang S,. A comparison of the effectiveness between amniotic membrane homogenate and transplanted amniotic membrane in healing corneal damage in a rabbit model. Acta Ophthalmol 2011; 89: e315-319.
55. Moher D, Liberati A, Tetzlaff J, Altman D,; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.